Orchestra BioMed Holdings Inc. (OBIO)

Orchestra BioMed Holdings Inc. (OBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $358M; returns 1 day +2.2%, 1 week +2.6%, 1 year +47.1%.

Orchestra BioMed Holdings, Inc. (OBIO) is a biomedical innovation company focused on developing therapeutic products for unmet needs in procedure-based medicine. They utilize a partnership-enabled business model, collaborating with medical device companies to commercialize their products.

Groups OBIO belongs to

• Medical Devices
• Healthcare
• Biotechnology
• Healthcare Technology
• Clinical Stage
• Cardiovascular Therapies
• Strategic Partnerships
• Healthcare Innovation
• Minimally Invasive Surgery

OBIO financial model: income statement, cash flow and balance sheet